The Klow blend is an 80mg vial containing four peptides: GHK-Cu (50mg), KPV (10mg), BPC-157 (10mg), and TB-500 (10mg)
useful for upper GI targeting Troches buccal absorption, limited evidence specific to BPC-157 Who oral delivery is best suited for: Leaky gut / intestinal permeability Inflammatory bowel disease (IBD, Crohn's, ulcerative colitis) NSAID-induced gastric damage or ulcers Irritable bowel syndrome (IBS) General GI maintenance alongside other therapies Patients who cannot or will not self-inject Practical considerations: Oral bioavailability is lower for systemic goals do not expect injection-equivalent tendon or joint results Dosing protocols typically require three to ten times the injectable dose to achieve comparable GI effects Product quality varies widely in the oral supplement market sourcing from a licensed compounding pharmacy is essential Nasal BPC-157: Emerging Option, Limited Evidence Nasal BPC-157 is the third delivery route and the least established
Medical supervision is essential if considering peptides alongside any conventional psoriasis treatment
TFG- and other cytokines mediate this interaction
If you have questions about glutathione IV therapy cost, dosage selection, infusion length, mobile versus in clinic pricing, or safety protocols, our team is available to help
